Letters to the Editor

Prolonged survival with glofitamab in non-diffuse large B-cell lymphoma after CAR T-cell therapy relapse

Department of Hematology, University Hospital of Lyon, Lyon
Department of Hematology, University Hospital of Rennes, Rennes, France; UMR U1236, INSERM, University of Rennes, Rennes
Scintidoc Nuclear Medicine Center, Clinique Clémentville, Montpellier
Department of Hematology, Lymphoma Malignancies Unit, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris, Créteil
Department of Hematology, Cancer University Institute of Toulouse Oncopole, Toulouse; Centre de Recherches en Cancérologie de Toulouse. INSERM U1037, Toulouse
Department of Hematology, La Pitié Salpetrière Hospital, Assistance Publique- Hôpitaux de Paris, Paris
Department of Hematology, U1245, Henri Becquerel Institute, Rouen, France; INSERM U1245, Rouen
Department of Adults Cell Therapy and Clinical Hematology, University Hospital Clermont-Ferrand, Clermont-Ferrand
Department of Clinical Hematology and Cell Therapy, University Hospital of Bordeaux, Bordeaux
Department of Hematology, University Hospital of Lille, Lille, France; ULR
Department of Hematology, University Hospital Dijon Bourgogne, Dijon, France; INSERM U1231, CTM Equipe Epi2THM, Université Bourgogne Europe, Dijon
Department of Hematology, University Hospital, Nantes
Department of Onco-Hematology, Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; University of Paris Cité, Paris
Department of Hematology, University Hospital of Amiens, Amiens
Department of Hematology, Saint Antoine Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; INSERM U938 Sorbonne University, Paris
Department of Hematology, University Hospital of Grenoble, Grenoble
Department of Hematology, University Hospital of Tours, Tours
Department of Hematology, University Hospital of Nancy, Nancy, France; INSERM 1256, Nancy
Department of Hematology, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris
Department of Biostatistics, LYSARC, Lyon-Sud Hospital, Pierre-Bénite
UMR1236, SITI Laboratory, University Hospital, INSERM, EFS, Rennes
Department of Pathology, Cancer University Institute of Toulouse Oncopole, Toulouse, France; Centre de Recherches en Cancérologie de Toulouse, INSERM U1037, Toulouse
Department of Hematology, University Hospital of Montpellier, Montpellier, France; UMR CNRS 5535, Montpellier
Haematologica Early view May 21, 2026 https://doi.org/10.3324/haematol.2026.300537